FIELD: medicine.
SUBSTANCE: invention refers to medicine, and aims at treating chronic obstructive pulmonary disease (COPD). It involves the combined nebuliser therapy by means of introducing 25% magnesium sulphate 3.0 ml and one of the preparations: the M-cholinolytic 0.025% atrovent 0.25 ml or the β2-adrenoceptor agonist 0.1% berotec 0.25 ml, or the combination of the M-cholinolytic and the β2-adrenoceptor agonist berodual 0.25 ml for 5 minutes twice a day.
EFFECT: method allows achieving reduced dosages, frequency rate, duration of the use of drugs, and also reaching the more manifested improvement of bronchial passability in comparison with the bronchial spasmolytic monotherapy due to total bronchodilatatory effects of magnesium sulphate and M-cholinolytic and/or β2- adrenoceptor agonist.
4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING BRONCHIAL ASTHMA IN CHILDREN IN ATTACK PERIOD | 2002 |
|
RU2236219C2 |
METHOD OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE ACCOMPANIED BY BRONCHIECTASIA | 2010 |
|
RU2464017C2 |
METHOD OF TREATING CHRONIC OBSTRUCTIVE BRONCHITIS | 2015 |
|
RU2600822C1 |
METHOD OF TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2600833C1 |
METHOD FOR DIAGNOSING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2023 |
|
RU2824421C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2012 |
|
RU2488830C1 |
METHOD OF TREATMENT OF PATIENTS WITH BRONCHOOBSTRUCTIVE SYNDROME | 1996 |
|
RU2136273C1 |
METHOD FOR TREATMENT OF PATIENT WITH CHRONIC OBSTRUCTIVE LUNG DISEASE | 2005 |
|
RU2293556C2 |
METHOD OF TREATING PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE | 2011 |
|
RU2464007C1 |
AEROSOL FOR INHALATIONS OF GLUTOVENT PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS USING IN THERAPY | 2001 |
|
RU2190422C1 |
Authors
Dates
2012-08-20—Published
2011-04-07—Filed